These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25837440)

  • 1. Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity.
    Kwon YS; Cho YN; Kim MJ; Jin HM; Jung HJ; Kang JH; Park KJ; Kim TJ; Kee HJ; Kim N; Kee SJ; Park YW
    Tuberculosis (Edinb); 2015 May; 95(3):267-74. PubMed ID: 25837440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.
    Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW
    J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis.
    Jiang J; Wang X; An H; Yang B; Cao Z; Liu Y; Su J; Zhai F; Wang R; Zhang G; Cheng X
    Am J Respir Crit Care Med; 2014 Aug; 190(3):329-39. PubMed ID: 24977786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal-Associated Invariant T Cell Levels Are Reduced in the Peripheral Blood and Lungs of Children With Active Pulmonary Tuberculosis.
    Malka-Ruimy C; Ben Youssef G; Lambert M; Tourret M; Ghazarian L; Faye A; Caillat-Zucman S; Houdouin V
    Front Immunol; 2019; 10():206. PubMed ID: 30853958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting.
    Balfour A; Schutz C; Goliath R; Wilkinson KA; Sayed S; Sossen B; Kanyik JP; Ward A; Ndzhukule R; Gela A; Lewinsohn DM; Lewinsohn DA; Meintjes G; Shey M
    Front Immunol; 2021; 12():648216. PubMed ID: 33828558
    [No Abstract]   [Full Text] [Related]  

  • 6. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
    Wang MS; Wang JL; Wang XF
    BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient 5-OP-RU-Induced Enrichment of Mucosa-Associated Invariant T Cells in the Murine Lung Does Not Enhance Control of Aerosol Mycobacterium tuberculosis Infection.
    Vorkas CK; Levy O; Skular M; Li K; Aubé J; Glickman MS
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal-associated invariant T cells from patients with tuberculosis exhibit impaired immune response.
    Jiang J; Yang B; An H; Wang X; Liu Y; Cao Z; Zhai F; Wang R; Cao Y; Cheng X
    J Infect; 2016 Mar; 72(3):338-52. PubMed ID: 26724769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551.
    Bucsan AN; Rout N; Foreman TW; Khader SA; Rengarajan J; Kaushal D
    Tuberculosis (Edinb); 2019 May; 116S():S11-S18. PubMed ID: 31072689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal-Associated Invariant T Cell Deficiency in Chronic Obstructive Pulmonary Disease.
    Kwon YS; Jin HM; Cho YN; Kim MJ; Kang JH; Jung HJ; Park KJ; Kee HJ; Kee SJ; Park YW
    COPD; 2016; 13(2):196-202. PubMed ID: 26552490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency and dynamics of CD4
    Xiong K; Sun W; Wang H; Xie J; Su B; Fan L
    Cell Immunol; 2021 Jul; 365():104381. PubMed ID: 34049011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.
    Lee OJ; Cho YN; Kee SJ; Kim MJ; Jin HM; Lee SJ; Park KJ; Kim TJ; Lee SS; Kwon YS; Kim N; Shin MG; Shin JH; Suh SP; Ryang DW; Park YW
    Exp Gerontol; 2014 Jan; 49():47-54. PubMed ID: 24269212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Interferon-Gamma Release Assay in Patients with Non-Tuberculous Mycobacteria Pulmonary Disease.
    Jia H; Pan L; Wang G; Duan H; Song Z; Sun Q; Wei R; Du B; Xing A; Zhang Z
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
    Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
    Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiencies of Circulating Mucosal-associated Invariant T Cells and Natural Killer T Cells in Patients with Acute Cholecystitis.
    Kim JC; Jin HM; Cho YN; Kwon YS; Kee SJ; Park YW
    J Korean Med Sci; 2015 May; 30(5):606-11. PubMed ID: 25931792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls.
    Suliman S; Gela A; Mendelsohn SC; Iwany SK; Tamara KL; Mabwe S; Bilek N; Darboe F; Fisher M; Corbett AJ; Kjer-Nielsen L; Eckle SBG; Huang CC; Zhang Z; Lewinsohn DM; McCluskey J; Rossjohn J; Hatherill M; León SR; Calderon RI; Lecca L; Murray M; Scriba TJ; Van Rhijn I; Moody DB
    J Infect Dis; 2020 Aug; 222(6):995-1007. PubMed ID: 32267943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood MR1 tetramer-positive mucosal-associated invariant T-cell function is modulated by mammalian target of rapamycin complex 1 in patients with active tuberculosis.
    Zhou CY; Yang YL; Han ZY; Chen YX; Liu HL; Fan K; Li MC; Tu SH; Wen Q; Zhou XY; Ma L
    Immunology; 2024 Nov; 173(3):497-510. PubMed ID: 39022997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical and laboratory findings between those with pulmonary tuberculosis and those with nontuberculous mycobacterial lung disease.
    Thanachartwet V; Desakorn V; Duangrithi D; Chunpongthong P; Phojanamongkolkij K; Jitruckthai P; Kasetjaroen Y; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):85-94. PubMed ID: 24964657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence.
    Dey RJ; Dey B; Harriff M; Canfield ET; Lewinsohn DM; Bishai WR
    mBio; 2021 Feb; 13(1):e0386521. PubMed ID: 35164552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of T-SPOT.TB in Early Diagnosis of Tracheobronchial Tuberculosis.
    Han J; Zeng F; Zhou Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):336-41. PubMed ID: 26847101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.